Biobijou Co

Biobijou Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Biobijou Co (489460.KQ) as of Oct 30, 2026 is -85.67 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 5.29 % — a change of -1,718.54% (lower).

FCF Conversion

-85.67 %

YoY

-1,718.54%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Biobijou Co is 2025 -85.67 % . FCF Conversion Rate (FCF/EBITDA) of Biobijou Co was 2024 5.29 % . It decreases by -1,718.54% lower compared to the previous year.

The Biobijou Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2022
245.76 KRW
Jan 1, 2023
120.72 KRW
Jan 1, 2024
5.29 KRW
Jan 1, 2025
-85.67 KRW
The Biobijou Co FCF Conversion history
YEARFCF ConversionYoY
-85.67 %-1,718.54%
5.29 %-95.62%
120.72 %-50.88%
245.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biobijou Co Stock analysis

What does Biobijou Co do? Biobijou Co Ltd is a South Korean pharmaceutical company based in Hanam, Gyeonggi-Do, operating within the Health Care sector. The company focuses on the research, development, manufacturing, and sale of skin booster and filler products utilizing hyaluronic acid and various materials for the global aesthetic market. It also produces cosmetic products including masks, mists, and creams. Biobijou Co Ltd completed its initial public offering on May 20, 2025, with the ticker symbol 489460.KQ and ISIN KR74860006. The company's website is http://www.biobijou.co.kr. It operates as an export-oriented business, targeting international markets for its aesthetic and cosmetic product lines. The firm's primary activities involve the production and distribution of hyaluronic acid-based skin care solutions and related cosmetic items. As a newly listed entity, Biobijou Co Ltd is positioned within the pharmaceutical and cosmetic industries, emphasizing innovation in aesthetic treatments. The company's operations are centered in Hanam, South Korea, with an emphasis on global market expansion through its export strategy. Biobijou Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biobijou Co stock

FCF Conversion Rate (FCF/EBITDA) of Biobijou Co is -85.67 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Biobijou Co changed from 5.29 % to -85.67 %, representing a -1,718.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Biobijou Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Biobijou Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Biobijou Co

All Key Metrics — Biobijou Co